Skip to content

    Alkyl Amines Chemicals Q4 FY26 earnings call

    ALKYLAMINE
    Chemicals·6 May 2026
    Management Summary

    Alkyl Amines Chemicals Limited reported a flat top-line and bottom-line for Q4 FY26, with volumes and values remaining largely unchanged from the previous year. The company navigated significant raw material price volatility, particularly for ammonia, and managed to pass on increased costs to customers. While facing challenges from a new competitor in methylamines and a slight delay in its Kurkumbh project, management expressed cautious optimism for improved margins and 5-10% volume growth in FY27, driven by a reduction in Chinese aggressive pricing and a focus on specialty products.

    Highlights

    5

    • Managed to retain and perhaps even slightly increase market share in various markets.

    • Successfully overcame operational challenges related to ammonia sourcing in March.

    • Acetonitrile pricing improved towards year-end, leading to increased volumes and market share.

    • Ethylamine market adjusted, with improved margins and stabilized prices.

    • Expressed cautious optimism for better times ahead, believing the worst is over.

    Concerns

    5

    • Markets have not grown as fast as desired.

    • Future remains uncertain due to ongoing war, impacting supply chains.

    • Kurkumbh project slightly delayed, now expected in early Q1 FY27.

    • Overcapacity and increased competition in methylamines due to a new player (Aarti).

    • Potential for demand destruction due to higher pricing, though not yet observed.

    Key financials

    Single quarter

    03 metrics
    1. 01Overall Tonnage Growth1%+1%YoY
    2. 02Acetonitrile Price (Current)200 Rs/kg
    3. 03Acetonitrile Price (Last Year Avg)145 Rs/kg

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Guidance & targets

    6
    CategoryTargetPriority
    Volume
    Overall Volume Growth
    5% to 10%
    		Medium
    Capacity
    Kurkumbh Project Commissioning
    beginning of the next quarter
    		High
    Capex
    Planned Capex (New Product & Engineering)
    INR80 crores to INR90 crores
    		High
    Capex
    Maintenance Capex
    INR20 crores, INR30 crores
    		High
    R&D
    Time to Commercialize New R&D Products
    almost 4 to 5 years
    		High
    Raw Material Sourcing
    Time for Green Ammonia Breakthroughs
    3 to 5 years
    		Medium

    What to watch in Q1 FY27

    5

    Kurkumbh Project Commissioning

    Next quarter (Q1 FY27)
    CurrentMechanical completion ongoing, slightly delayed
    TargetCommercial operations commenced

    Why it matters

    Timely commissioning of new capacity is crucial for future growth and operational expansion.

    It will probably be the beginning of the next quarter that the project get commissioned. Mechanical completion is going on. Mechanical completion is going to be completed somewhere at the end of June.

    Risks & concerns

    5
    RiskSeverity

    Future uncertainty due to ongoing war

    The future remains a little uncertain as long as the war continues, impacting supply chains. — Management acknowledged

    high

    Potential demand destruction from higher prices

    Difficult to predict if higher prices will impact demand, though not yet observed. — Management acknowledged

    medium

    Increased competition and overcapacity in methylamines

    Entry of a new player (Aarti) has led to 4 players and overcapacity, which will take time to fill. — Management acknowledged

    medium

    Market volatility affecting new project investment decisions

    The company is being cautious about major new investments (INR20-200 crores) until market volatility settles. — Management acknowledged

    medium

    El Nino impact on agro demand

    Some concern exists regarding the impact of El Nino on agro demand, though not yet observed. — Management acknowledged

    low

    Q&A highlights

    8

    “It is a bit difficult to predict whether this will have an impact on the demand. At the moment, of course, we haven't seen it because it's too early. But we have one thought process that in most of our customers' products, we are actually a very minor cost in their cost of material.”

    Addresses the immediate impact of raw material price increases on demand and the company's ability to pass on costs, noting that their products are often a minor cost for customers.

    asked by Rohit Nagraj

    2 min read6 chapters

    Detailed Narrative

    01

    Overall Performance and Market Conditions

    Alkyl Amines Chemicals Limited reported a challenging Q4 FY26, with both top-line and bottom-line remaining flat, plus/minus 1% compared to the previous year. Overall volume and value also saw a slight combined drop of about 2%. Despite these challenges, the company successfully managed to retain or slightly increase its market share in various operating markets.

    02

    Raw Material and Pricing Dynamics

    Raw material prices, particularly for ammonia, experienced significant volatility, rising from approximately INR50/kg to over INR100/kg. The company was able to pass these increased costs on to customers, noting that their products typically represent a minor cost in the customers' overall material expenses. Operational disruptions related to ammonia sourcing in March were largely mitigated through improved supplier relations and existing inventories.

    03

    Capacity and Project Updates

    The Kurkumbh project, a key capacity expansion initiative, is now slightly delayed and is expected to be commissioned at the beginning of Q1 FY27, with mechanical completion targeted for the end of June. The company maintains a healthy capacity utilization rate of 60-85% across its plants and believes it has sufficient ethylamine capacity for the next 4-5 years, assuming a natural growth rate.

    04

    R&D and New Product Development

    The company has an active R&D pipeline with 'over a dozen projects' at various stages of development. However, new major investments in these projects are being approached cautiously due to current market volatility🌐. Management estimates that the commercialization of new R&D products typically takes 'almost 4 to 5 years' from conceptualization to market entry.

    05

    Competitive Landscape and China Impact

    The acetonitrile market saw improved pricing and increased market share for Alkyl Amines towards the end of the year, as Chinese competitors reduced aggressive pricing. Conversely, the methylamines segment faces heightened competition due to the entry of a new player (Aarti), leading to overcapacity with four major players in the market, which is expected to pressure margins.

    06

    Outlook and Growth Targets

    Management expresses cautious optimism for FY27, projecting a 'normal year' with an expected 5-10% volume growth rate, though acknowledging future uncertainties. They anticipate improved margins as raw material prices are not expected to quickly revert to pre-February levels. Planned capex for FY27 and FY28 is estimated at INR80-90 crores for new product plants and engineering projects, supplemented by INR20-30 crores for annual maintenance capex.

    This is an AI-generated summary of a publicly available earnings call transcript.